View Latest Medical and Pharma Bids and Tenders

Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Estradiol (Atc Code: G03Cd03, G03Ca03).

Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Estradiol (Atc Code: G03Cd03, G03Ca03).

Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Estradiol (G03Ca03) As Part Of A So-Called Open House Model.

Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Estradiol (G03Ca03) Within The Framework Of A So-Called Open-House Model.

Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Estradiol (G03Ca03) As Part Of A So-Called Open House Model.

Completion Of A Non-Exclusive Discount Contract According To Section 130A Paragraph 8 Sgb V For Dienogest, Estradiol, Atc Code: G03Fa15 For The Period From November 1St, 2023 To October 31St, 2025

Conclusion Of Non-Exclusive Discount Agreements According To § 130 A Paragraph 8 Sgb V For Drugs With The Active Ingredient Dienogest + Estradiol Tab

Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Nomegestrol + Estradiol, Atc G03Aa14 For The Period August 1St, 2023 - July 31St, 2025

Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Nomegestrol + Estradiol, Atc G03Aa14 For The Period August 1St, 2023 - July 31St, 2025

Open House Contract Etonogestrel And Ethinylestradiol